The chief executive officer of Likarda discussed the company’s CSS technology and how it may reduce off-tissue effects.
Stella Vnook, PharmD
Advertisement
Articles by Stella Vnook, PharmD
Advertisement
Latest Updated Articles
Stella Vnook, PharmD, on Improving Cell Therapy Delivery to Solid Tumors With Core Shell SpherificationPublished: November 2nd 2023 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
FDA Hits Atara Biotherapeutics’ T-Cell Immunotherapy Tabelecleucel for EBV+ PTLD With Second CRL
2
Around the Helix: Cell and Gene Therapy Company Updates – January 14, 2026
3
Steven W. Pipe, MD, on Integrating Gene Therapy into Clinical Care for Hemophilia B
4
Brian Lin, PhD, on Using Genetics, Biomarkers, and Clinical Trial Readiness to Enhance ALS Care
5